We report the case of a 5-year-old girl who presented with 2 blue-red atrophic plaques on the left leg as well as subcutaneous nodules that were present since infancy. Although the clinical criteria of neurofibromatosis (NF) were absent, microscopic examination revealed features of a blue-red neurofibroma.

Download full-text PDF

Source

Publication Analysis

Top Keywords

rare case
4
case segmental
4
segmental neurofibromatosis
4
neurofibromatosis multiple
4
multiple blue-red
4
blue-red pseudoatrophic
4
pseudoatrophic plaques
4
plaques report
4
report case
4
case 5-year-old
4

Similar Publications

Mixed neuroendocrine-non-neuroendocrine neoplasm (MiNEN) of the colon is rare with a poor prognosis. Since the first description of a mixed neoplasm 100 years ago, the nomenclature has evolved, most recently with the 2022 World Health Organization (WHO) classification system. We describe our experience of a case of locoregionally advanced MiNEN of the descending colon treated with curative laparoscopic resection and adjuvant chemotherapy.

View Article and Find Full Text PDF

Making the Case for an International Childhood Cancer Data Partnership.

J Natl Cancer Inst

January 2025

Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.

Childhood cancers are a heterogeneous group of rare diseases, accounting for less than 2% of all cancers diagnosed worldwide. Most countries, therefore, do not have enough cases to provide robust information on epidemiology, treatment, and late effects, especially for rarer types of cancer. Thus, only through a concerted effort to share data internationally will we be able to answer research questions that could not otherwise be answered.

View Article and Find Full Text PDF

Mitochondrial HMG-CoA synthase deficiency.

Mol Genet Metab

January 2025

Clinical Department of Laboratory Medicine, University Hospitals Leuven, Leuven, Belgium; Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium. Electronic address:

Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase 2 (HMGCS2) deficiency is a rare, potentially life-threatening autosomal recessive disorder resulting from mutations in the HMGCS2 gene, leading to impaired ketogenesis. We systematically reviewed the clinical presentations, biochemical and genetic abnormalities in 93 reported cases and 2 new patients diagnosed based on biochemical findings. Reported onset ages ranged from 3 months to 6 years, mostly before the age of 3.

View Article and Find Full Text PDF

Background: Aarskog-Scott syndrome (AAS) is a rare condition with multiple congenital anomalies, caused by hemizygote variants in the gene. Its description was based mostly on old case reports, in whom a molecular diagnosis was not always available, or on small series. The aim of this study was to better delineate the phenotype and the natural history of AAS and to provide clues for the diagnosis and the management of the patients.

View Article and Find Full Text PDF

Three symptomatic cases of myoma uteri in adolescence, one of which is STUMP tumor.

J Pediatr Adolesc Gynecol

January 2025

Department of Obstetrics and Gynecology, University of Health Sciences, Bagcilar Training and Research Hospital, Istanbul, Turkey. Electronic address:

Article Synopsis
  • Uterine leiomyomas, although rare in adolescents, can present with symptoms like abnormal bleeding and pelvic pain, with smooth muscle tumors of unknown malignant potential (STUMP) being even rarer.
  • In a hospital case study, three 19-year-old patients presented with significant symptoms, leading to the identification of varying sizes of uterine myomas; one was diagnosed as a STUMP tumor while the others were benign fibroids.
  • Despite their rarity, it is important for healthcare providers to consider uterine myomas and STUMP tumors as potential diagnoses in young patients experiencing pelvic symptoms.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!